PRR adjuvants restrain high stability peptides presentation on APCs

Adjuvants can affect APCs function and boost adaptive immune responses post-vaccination. However, whether they modulate the specificity of immune responses, particularly immunodominant epitope responses, and the mechanisms of regulating antigen processing and presentation remain poorly defined. Here...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:eLife 2024-10, Vol.13
Hauptverfasser: Li, Bin, Zhang, Jin, He, Taojun, Yuan, Hanmei, Wu, Hui, Wang, Peng, Wu, Chao
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title eLife
container_volume 13
creator Li, Bin
Zhang, Jin
He, Taojun
Yuan, Hanmei
Wu, Hui
Wang, Peng
Wu, Chao
description Adjuvants can affect APCs function and boost adaptive immune responses post-vaccination. However, whether they modulate the specificity of immune responses, particularly immunodominant epitope responses, and the mechanisms of regulating antigen processing and presentation remain poorly defined. Here, using overlapping synthetic peptides, we screened the dominant epitopes of Th1 responses in mice post-vaccination with different adjuvants and found that the adjuvants altered the antigen-specific CD4 + T-cell immunodominant epitope hierarchy. MHC-II immunopeptidomes demonstrated that the peptide repertoires presented by APCs were significantly altered by the adjuvants. Unexpectedly, no novel peptide presentation was detected after adjuvant treatment, whereas peptides with high binding stability for MHC-II presented in the control group were missing after adjuvant stimulation, particularly in the MPLA- and CpG-stimulated groups. The low-stability peptide present in the adjuvant groups effectively elicited robust T-cell responses and formed immune memory. Collectively, our results suggest that adjuvants (MPLA and CpG) inhibit high-stability peptide presentation instead of revealing cryptic epitopes, which may alter the specificity of CD4 + T-cell-dominant epitope responses. The capacity of adjuvants to modify peptide–MHC (pMHC) stability and antigen-specific T-cell immunodominant epitope responses has fundamental implications for the selection of suitable adjuvants in the vaccine design process and epitope vaccine development.
doi_str_mv 10.7554/eLife.99173.3
format Article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_7554_eLife_99173_3</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_7554_eLife_99173_3</sourcerecordid><originalsourceid>FETCH-crossref_primary_10_7554_eLife_99173_33</originalsourceid><addsrcrecordid>eNqVjrEKwjAYhIMoWLSje16gNTEtbUcpioNDEQe3EG1qU2oa8kehb28tDq4eB3fDN3wIrSgJkziO1vKoKhlmGU1YyCbI25CYBCSNLtOfP0c-QEOGJFGa0sxDeXE6YVE2z5fQDrCV4KxQGtfqXmNw4qpa5XpspHGqlIDNQEjthFOdxkO3RQ5LNKtEC9L_7gIF-905PwQ32wFYWXFj1UPYnlPCP7J8lOWjLGfsX_4NdFhIRA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>PRR adjuvants restrain high stability peptides presentation on APCs</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Li, Bin ; Zhang, Jin ; He, Taojun ; Yuan, Hanmei ; Wu, Hui ; Wang, Peng ; Wu, Chao</creator><creatorcontrib>Li, Bin ; Zhang, Jin ; He, Taojun ; Yuan, Hanmei ; Wu, Hui ; Wang, Peng ; Wu, Chao</creatorcontrib><description>Adjuvants can affect APCs function and boost adaptive immune responses post-vaccination. However, whether they modulate the specificity of immune responses, particularly immunodominant epitope responses, and the mechanisms of regulating antigen processing and presentation remain poorly defined. Here, using overlapping synthetic peptides, we screened the dominant epitopes of Th1 responses in mice post-vaccination with different adjuvants and found that the adjuvants altered the antigen-specific CD4 + T-cell immunodominant epitope hierarchy. MHC-II immunopeptidomes demonstrated that the peptide repertoires presented by APCs were significantly altered by the adjuvants. Unexpectedly, no novel peptide presentation was detected after adjuvant treatment, whereas peptides with high binding stability for MHC-II presented in the control group were missing after adjuvant stimulation, particularly in the MPLA- and CpG-stimulated groups. The low-stability peptide present in the adjuvant groups effectively elicited robust T-cell responses and formed immune memory. Collectively, our results suggest that adjuvants (MPLA and CpG) inhibit high-stability peptide presentation instead of revealing cryptic epitopes, which may alter the specificity of CD4 + T-cell-dominant epitope responses. The capacity of adjuvants to modify peptide–MHC (pMHC) stability and antigen-specific T-cell immunodominant epitope responses has fundamental implications for the selection of suitable adjuvants in the vaccine design process and epitope vaccine development.</description><identifier>ISSN: 2050-084X</identifier><identifier>EISSN: 2050-084X</identifier><identifier>DOI: 10.7554/eLife.99173.3</identifier><language>eng</language><ispartof>eLife, 2024-10, Vol.13</ispartof><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-crossref_primary_10_7554_eLife_99173_33</cites><orcidid>0000-0002-5592-6842 ; 0000-0002-8429-7109</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27924,27925</link.rule.ids></links><search><creatorcontrib>Li, Bin</creatorcontrib><creatorcontrib>Zhang, Jin</creatorcontrib><creatorcontrib>He, Taojun</creatorcontrib><creatorcontrib>Yuan, Hanmei</creatorcontrib><creatorcontrib>Wu, Hui</creatorcontrib><creatorcontrib>Wang, Peng</creatorcontrib><creatorcontrib>Wu, Chao</creatorcontrib><title>PRR adjuvants restrain high stability peptides presentation on APCs</title><title>eLife</title><description>Adjuvants can affect APCs function and boost adaptive immune responses post-vaccination. However, whether they modulate the specificity of immune responses, particularly immunodominant epitope responses, and the mechanisms of regulating antigen processing and presentation remain poorly defined. Here, using overlapping synthetic peptides, we screened the dominant epitopes of Th1 responses in mice post-vaccination with different adjuvants and found that the adjuvants altered the antigen-specific CD4 + T-cell immunodominant epitope hierarchy. MHC-II immunopeptidomes demonstrated that the peptide repertoires presented by APCs were significantly altered by the adjuvants. Unexpectedly, no novel peptide presentation was detected after adjuvant treatment, whereas peptides with high binding stability for MHC-II presented in the control group were missing after adjuvant stimulation, particularly in the MPLA- and CpG-stimulated groups. The low-stability peptide present in the adjuvant groups effectively elicited robust T-cell responses and formed immune memory. Collectively, our results suggest that adjuvants (MPLA and CpG) inhibit high-stability peptide presentation instead of revealing cryptic epitopes, which may alter the specificity of CD4 + T-cell-dominant epitope responses. The capacity of adjuvants to modify peptide–MHC (pMHC) stability and antigen-specific T-cell immunodominant epitope responses has fundamental implications for the selection of suitable adjuvants in the vaccine design process and epitope vaccine development.</description><issn>2050-084X</issn><issn>2050-084X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNqVjrEKwjAYhIMoWLSje16gNTEtbUcpioNDEQe3EG1qU2oa8kehb28tDq4eB3fDN3wIrSgJkziO1vKoKhlmGU1YyCbI25CYBCSNLtOfP0c-QEOGJFGa0sxDeXE6YVE2z5fQDrCV4KxQGtfqXmNw4qpa5XpspHGqlIDNQEjthFOdxkO3RQ5LNKtEC9L_7gIF-905PwQ32wFYWXFj1UPYnlPCP7J8lOWjLGfsX_4NdFhIRA</recordid><startdate>20241030</startdate><enddate>20241030</enddate><creator>Li, Bin</creator><creator>Zhang, Jin</creator><creator>He, Taojun</creator><creator>Yuan, Hanmei</creator><creator>Wu, Hui</creator><creator>Wang, Peng</creator><creator>Wu, Chao</creator><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0002-5592-6842</orcidid><orcidid>https://orcid.org/0000-0002-8429-7109</orcidid></search><sort><creationdate>20241030</creationdate><title>PRR adjuvants restrain high stability peptides presentation on APCs</title><author>Li, Bin ; Zhang, Jin ; He, Taojun ; Yuan, Hanmei ; Wu, Hui ; Wang, Peng ; Wu, Chao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-crossref_primary_10_7554_eLife_99173_33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Li, Bin</creatorcontrib><creatorcontrib>Zhang, Jin</creatorcontrib><creatorcontrib>He, Taojun</creatorcontrib><creatorcontrib>Yuan, Hanmei</creatorcontrib><creatorcontrib>Wu, Hui</creatorcontrib><creatorcontrib>Wang, Peng</creatorcontrib><creatorcontrib>Wu, Chao</creatorcontrib><collection>CrossRef</collection><jtitle>eLife</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Li, Bin</au><au>Zhang, Jin</au><au>He, Taojun</au><au>Yuan, Hanmei</au><au>Wu, Hui</au><au>Wang, Peng</au><au>Wu, Chao</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>PRR adjuvants restrain high stability peptides presentation on APCs</atitle><jtitle>eLife</jtitle><date>2024-10-30</date><risdate>2024</risdate><volume>13</volume><issn>2050-084X</issn><eissn>2050-084X</eissn><abstract>Adjuvants can affect APCs function and boost adaptive immune responses post-vaccination. However, whether they modulate the specificity of immune responses, particularly immunodominant epitope responses, and the mechanisms of regulating antigen processing and presentation remain poorly defined. Here, using overlapping synthetic peptides, we screened the dominant epitopes of Th1 responses in mice post-vaccination with different adjuvants and found that the adjuvants altered the antigen-specific CD4 + T-cell immunodominant epitope hierarchy. MHC-II immunopeptidomes demonstrated that the peptide repertoires presented by APCs were significantly altered by the adjuvants. Unexpectedly, no novel peptide presentation was detected after adjuvant treatment, whereas peptides with high binding stability for MHC-II presented in the control group were missing after adjuvant stimulation, particularly in the MPLA- and CpG-stimulated groups. The low-stability peptide present in the adjuvant groups effectively elicited robust T-cell responses and formed immune memory. Collectively, our results suggest that adjuvants (MPLA and CpG) inhibit high-stability peptide presentation instead of revealing cryptic epitopes, which may alter the specificity of CD4 + T-cell-dominant epitope responses. The capacity of adjuvants to modify peptide–MHC (pMHC) stability and antigen-specific T-cell immunodominant epitope responses has fundamental implications for the selection of suitable adjuvants in the vaccine design process and epitope vaccine development.</abstract><doi>10.7554/eLife.99173.3</doi><orcidid>https://orcid.org/0000-0002-5592-6842</orcidid><orcidid>https://orcid.org/0000-0002-8429-7109</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 2050-084X
ispartof eLife, 2024-10, Vol.13
issn 2050-084X
2050-084X
language eng
recordid cdi_crossref_primary_10_7554_eLife_99173_3
source DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; PubMed Central
title PRR adjuvants restrain high stability peptides presentation on APCs
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-19T19%3A42%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=PRR%20adjuvants%20restrain%20high%20stability%20peptides%20presentation%20on%20APCs&rft.jtitle=eLife&rft.au=Li,%20Bin&rft.date=2024-10-30&rft.volume=13&rft.issn=2050-084X&rft.eissn=2050-084X&rft_id=info:doi/10.7554/eLife.99173.3&rft_dat=%3Ccrossref%3E10_7554_eLife_99173_3%3C/crossref%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true